Evidence map›Paper›PMID 37958911›Full record

ArticleInternational journal of molecular sciences2023

Incorporation of Pectin into Vaterite Microparticles Prevented Effects of Adsorbed Mucin on Neutrophil Activation.

Elena V Mikhalchik, Liliya N Maltseva, Roxalana K Firova, Marina A Murina, Irina V Gorudko, Daria V Grigorieva, Viktor A Ivanov, Ekaterina A Obraztsova, Dmitry V Klinov, Ekaterina V Shmeleva and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Elena V MikhalchikDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
Liliya N MaltsevaDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.ORCID 0000-0001-9003-6098
Roxalana K FirovaDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
Marina A MurinaDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
Irina V GorudkoDepartment of Biophysics, Belarusian State University, 220030 Minsk, Belarus.
Daria V GrigorievaDepartment of Biophysics, Belarusian State University, 220030 Minsk, Belarus.ORCID 0000-0003-0210-5474
Viktor A IvanovDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
Ekaterina A ObraztsovaDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
Dmitry V KlinovDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
Ekaterina V ShmelevaDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
Sergey A GusevDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.ORCID 0000-0003-0383-2649
Oleg M PanasenkoDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.ORCID 0000-0001-5245-2285
Alexey V SokolovDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.ORCID 0000-0001-9033-0537
Nikolay P GorbunovDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.ORCID 0000-0003-4636-0565
Lyubov Y FilatovaDepartment of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.
Nadezhda G BalabushevichDepartment of Biophysics, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
Federal Medical-Biological Agency · RULomonosov Moscow State University · RUBelarusian State University · BYInstitute of Experimental Medicine · RUMoscow Institute of Physics and Technology · RU

Funding

Belarusian Republican Foundation for Basic Research B23RNF-093Development program of Lomonosov Moscow State University and registration theme 121041500039-8Russian Science Foundation 23-45-10026
6 · The paper itself

Abstract

The application of vaterite microparticles for mucosal delivery depends on their interaction with mucin and immune cells. As we have shown previously, the binding of mucin onto particles enhances the generation of reactive oxygen species by neutrophils. The attenuation of the pro-oxidant effect of the bound mucin through the modification of vaterite could improve its biocompatibility. Hybrid microparticles composed of vaterite and pectin (CCP) were prepared using co-precipitation. In comparison with vaterite (CC), they had a smaller diameter and pores, a greater surface area, and a negative zeta-potential. We aimed to study the cytotoxicity and mucin-dependent neutrophil-activating effect of CCP microparticles. The incorporated pectin did not influence the neutrophil damage according to a lactate dehydrogenase test. The difference in the CC- and CCP-elicited luminol or lucigenin chemiluminescence of neutrophils was insignificant, with no direct pro- or antioxidant effects from the incorporated pectin. Unlike soluble pectin, the CCP particles were ineffective at scavenging radicals in an ABAP-luminol test. The fluorescence of SYTOX Green demonstrated a CCP-stimulated formation of neutrophil extracellular traps (NETs). The pre-treatment of CC and CCP with mucin resulted in a 2.5-times-higher CL response of neutrophils to the CC-mucin than to the CCP-mucin. Thus, the incorporation of pectin into vaterite microspheres enabled an antioxidant effect to be reached when the neutrophils were activated by mucin-treated microparticles, presumably via exposed ligands.

Indexed as

Calcium CarbonatePectinsAntioxidantsLuminolMucinsNeutrophil ActivationNeutrophilsReactive Oxygen SpeciesAntioxidantsCalcium CarbonateLuminolMucinsPectinsReactive Oxygen Speciesantioxidantschemiluminescencecytotoxicityhybrid vaterite microparticlesmucinneutrophilspectinvaterite

Identifiers

PMID37958911
PMCPMC10649924
OpenAlexW4388303442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.